Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1995 Aug;73(2):154–156. doi: 10.1136/adc.73.2.154

A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension.

I Moncica 1, P I Oh 1, I ul Qamar 1, D Scolnik 1, G S Arbus 1, D Hebert 1, J W Balfe 1, G Koren 1
PMCID: PMC1511218  PMID: 7574861

Abstract

In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.

Full text

PDF
154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dillon M. J. Investigation and management of hypertension in children. A personal perspective. Pediatr Nephrol. 1987 Jan;1(1):59–68. doi: 10.1007/BF00866886. [DOI] [PubMed] [Google Scholar]
  2. Frishman W. H., Charlap S. Nifedipine in the treatment of systemic hypertension. Arch Intern Med. 1984 Dec;144(12):2335–2336. [PubMed] [Google Scholar]
  3. Morgan T. O. A review of the antihypertensive effects of felodipine alone or in combination. J Cardiovasc Pharmacol. 1990;15 (Suppl 4):S76–S84. doi: 10.1097/00005344-199015004-00025. [DOI] [PubMed] [Google Scholar]
  4. Shope J. T. Medication compliance. Pediatr Clin North Am. 1981 Feb;28(1):5–21. doi: 10.1016/s0031-3955(16)33959-1. [DOI] [PubMed] [Google Scholar]
  5. Spivack C., Ocken S., Frishman W. H. Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs. 1983 Feb;25(2):154–177. doi: 10.2165/00003495-198325020-00004. [DOI] [PubMed] [Google Scholar]
  6. Todd P. A., Faulds D. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Drugs. 1992 Aug;44(2):251–277. doi: 10.2165/00003495-199244020-00008. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES